MG132 induced apoptosis pathway in HL-60 cells and impact of allogeneic mixed lymphocyte reaction

被引:1
作者
Zhou, Yong-ming [1 ,2 ]
Guo, Wei [3 ]
Zhou, Hao [4 ]
Zhang, Jin-hua [1 ]
Liu, Zhi-ping [1 ]
Yu, Mei-xia [1 ]
机构
[1] Wuhan Univ Sci & Technol, Affiliated Tianyou Hosp, Dept Hematol, Wuhan 430064, Peoples R China
[2] Jiujiang Univ, Affiliated Hosp, Dept Hematol, Jiujiang 33200, Peoples R China
[3] Wuhan 1 Hosp, Dept Endocrinol, Wuhan 430032, Peoples R China
[4] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Hematol, Union Hosp, Wuhan 430030, Peoples R China
关键词
Proteasome inhibitor MG132; Apoptosis; p21; protein; p27; Allogeneic mixed lymphocyte reaction; PROTEASOME INHIBITOR PS-341; FACTOR-KAPPA-B; HL60; CELLS; CANCER; DIFFERENTIATION; EXPRESSION; P21; THERAPY; PROTEIN; TARGET;
D O I
10.1007/s11670-009-0333-z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To investigate the proteasome inhibitor MG132-induced apoptosis pathway in HL-60 cells and the role of allogeneic mixed lymphocyte reaction. Cell apoptosis was analyzed by flow cytometry. The expressions of p21 protein, p27 protein and p53 protein in HL-60 cells treated with MG132 were measured by Western blot. The proliferation of, peripheral blood mononuclear cells (PBMNCs) after treatment with 75 Gy irradiated HL-60 cells treated with MG132 was measured with CCK-8. High-dose MG132 induced apoptosis in HL-60 cells. No significant change was observed in MG132-induced apoptosis after inhibiting caspase-8 and caspase-9 pathway. The expressions of p21 protein and p27 protein increased in MG132-induced apoptosis. HL-60 cells treated with low-dose MG132 improved the proliferation of PBMNCs from healthy volunteers. High-dose MG132 induced apoptosis and directly killed HL-60 cells. MG132 induced apoptosis in a caspase-8- and caspase-9-independent pathway. p21 protein and p27 protein were involved in MG132-induced apoptosis in HL-60 cells. HL-60 cells treated with Low-dose MG132 improved the effect of promoting the proliferation of PBMNCs from healthy volunteers.
引用
收藏
页码:333 / 339
页数:7
相关论文
共 29 条
  • [1] Adams J, 1999, CANCER RES, V59, P2615
  • [2] Development of the proteasome inhibitor PS-341
    Adams, J
    [J]. ONCOLOGIST, 2002, 7 (01) : 9 - 16
  • [3] Cusack JC, 2001, CANCER RES, V61, P3535
  • [4] MAPK-dependent expression of p21WAF and p27kip1 in PMA-induced differentiation of HL60 cells
    Das, D
    Pintucci, G
    Stern, A
    [J]. FEBS LETTERS, 2000, 472 (01) : 50 - 52
  • [5] The proteasome, a novel protease regulated by multiple mechanisms
    DeMartino, GN
    Slaughter, CA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (32) : 22123 - 22126
  • [6] Inhibition of proteasome function induced apoptosis in gastric cancer
    Fan, XM
    Wong, BCY
    Wang, WP
    Zhou, XM
    Cho, CH
    Yuen, ST
    Leung, SY
    Lin, MCM
    Kung, HF
    Lam, SK
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2001, 93 (04) : 481 - 488
  • [7] Molecular mechanism of violacein-mediated human leukemia cell death
    Ferreira, CV
    Bos, CL
    Versteeg, HH
    Justo, GZ
    Durán, N
    Peppelenbosch, MP
    [J]. BLOOD, 2004, 104 (05) : 1459 - 1464
  • [8] Proteasome inhibitors can alter the signaling pathways and attenuate the P-glycoprotein-mediated multidrug resistance
    Fujita, T
    Washio, K
    Takabatake, D
    Takahashi, H
    Yoshitomi, S
    Tsukuda, K
    Ishibe, Y
    Ogasawara, Y
    Doihara, H
    Shimizu, N
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2005, 117 (04) : 670 - 682
  • [9] The ubiquitin-proteasome proteolytic pathway: Destruction for the sake of construction
    Glickman, MH
    Ciechanover, A
    [J]. PHYSIOLOGICAL REVIEWS, 2002, 82 (02) : 373 - 428
  • [10] Goldberg AL, 1997, BIOL CHEM, V378, P131